PLA2G16 anticorps (C-Term)
Aperçu rapide pour PLA2G16 anticorps (C-Term) (ABIN651933)
Antigène
Voir toutes PLA2G16 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 104-132, C-Term
-
Purification
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
-
Immunogène
- This HRASLS3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 104-132 amino acids from the C-terminal region of human HRASLS3.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000. FC: 1:10~50
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Date de péremption
- 6 months
-
-
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
-
Autre désignation
- HRASLS3
-
Sujet
- PLA2G16 specifically catalyzes the release of fatty acids from phospholipids in adipose tissue. It also has a weak lysophospholipase activity (By similarity). Tumor suppressor that may be involved in interferon-dependent cell death.
-
Poids moléculaire
- 17937
-
ID gène
- 11145
-
NCBI Accession
- NP_001121675, NP_009000
-
UniProt
- P53816
-
Pathways
- Inositol Metabolic Process
Antigène
-